Low Nanomolar Concentrations of Brusatol for Increasing the Efficacy of Photodynamic Therapy in Human Epidermoid Carcinoma Cells
Biomolecules · 19.11.2026 · 16 (11) · 1682
DOI: 10.3390/biom16111682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 19.11.2026. Verfasst von Dragos Paul Mihai und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carol Davila University of Medicine and Pharmacy.
Abstract (Originalsprache)
Background/Objectives: Photodynamic therapy (PDT) generates tumour-killing oxidative damage, but cellular stress responses may limit its effects. We investigated whether low nanomolar concentrations of brusatol (BRU) can increase the efficacy of milder regimens of PDT in human A-431 epidermoid carcinoma cells.
Methods
PDT was performed using the previously characterized P2.1 and P2.2 porphyrins. A-431 cells were exposed in vitro to PDT in the absence and presence of 20 nM BRU. Cellular viability, proliferation, and cellular electrical impedance, along with the expression changes of the HMOX1 and IL1B genes, were investigated. In vitro-treated A-431 cells were further implanted subcutaneously into immunocompromised mice to assess subsequent tumour growth.
Results
In the context of PDT, BRU induced a late decrease in the number of metabolically active tumour cells, with no significant changes in LDH release. An early and persistent decrease in the cellular electrical impedance was induced by BRU and PDT+BRU. These effects were accompanied by a persistent decrease in the expression level of the redox HMOX1 gene and up-regulation of the inflammatory IL1B gene. The in vitro treatment of tumour cells with BRU and/or PDT and their implantation in immunocompromised mice resulted in a decrease in tumour volume, but the in vitro PDT+BRU combination did not bring a benefit compared with in vitro PDT alone.
Conclusions
At low nanomolar concentrations, BRU can moderately increase the efficacy of milder PDT regimens in vitro. This is the first study to report that low BRU concentrations drastically inhibit cancer cell electrical impedance, with or without PDT, but the biological meaning needs further clarification. Nevertheless, it appears that repeated BRU administrations are needed to maintain its in vitro effect in the context of PDT.
Förderung
- Carol Davila University of Medicine and Pharmacy
Zitieren
APA
Mihai, D. P., Manda, G., Neagoe, I. V., Isvoranu, G., Dobre, M., Dinu-Pîrvu, C., Negres, S., & Boscencu, R. (2026). Low Nanomolar Concentrations of Brusatol for Increasing the Efficacy of Photodynamic Therapy in Human Epidermoid Carcinoma Cells. Biomolecules, 16(11), 1682. https://doi.org/10.3390/biom16111682
Vancouver
Mihai DP, Manda G, Neagoe IV, Isvoranu G, Dobre M, Dinu-Pîrvu C, et al. Low Nanomolar Concentrations of Brusatol for Increasing the Efficacy of Photodynamic Therapy in Human Epidermoid Carcinoma Cells. Biomolecules. 2026;16(11):1682. doi:10.3390/biom16111682
BibTeX
@article{Mihai2026,
author = {Mihai, Dragos Paul and Manda, Gina and Neagoe, Ionela Victoria and Isvoranu, Gheorghita and Dobre, Maria and Dinu-Pîrvu, Cristina-Elena and Negres, Simona and Boscencu, Rica},
title = {Low Nanomolar Concentrations of Brusatol for Increasing the Efficacy of Photodynamic Therapy in Human Epidermoid Carcinoma Cells},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1682},
doi = {10.3390/biom16111682}
}
EUVIMED